共 15 条
[1]
Effect of statin therapy on creactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomizen trial and cohort study. Albert MA,Danielson E,Rifai N,et al. The Journal of The American Medical Association . 2001
[2]
Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocytes cell line. Niwa S,Totsuka Y,Hayshi S. International Journal of Immunopharmacology . 1996
[3]
Atherogenic lipids, vascular dysfunction,and clinical signs of ischemic heart disease. Selwyn AP,Kinlay S,Libby P,et al. Circulation . 1997
[4]
HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. Bustos C,Hernandez-Presa MA,Ortego M,et al. Journal of the American College of Cardiology . 1998
[5]
Simvastatin an HMG-coenzyme a reductase inhibitor, improves endothelial function within 1 month. O Driscoll G,Green D,Taylor RR. Circulation . 1997
[6]
Beneficical effects of pravastatin (± colestyramine/niacin ) initiated immediately after a coronary event ( the randomized lipid-coronary artery disease[L-CAD]study ). Hans-Richard A,Rahul A,Werner W,et al. The American Journal of Cardiology . 2000
[7]
Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavan Simvastatin Survival Study ( 4S ). Scandinavian Simvastatin Survival Study Group. The Lancet . 1994
[8]
Cholesterol reduction rapidly improves endothelium function after acute coronary syndrome: the RECIFE (Reduction of Cholesterol in Ischemia and Function of the Endothelium) trial[see comments]. Dupuis J,Tardif JC,Cernacek P,et al. Circulation . 1999
[9]
Role of plaque rupture in acute coronary syndromes. Forrester JS. The American Journal of Cardiology . 2000
[10]
Platelet-dependent thrombin generation in patients with hyperlipidemia. Aoki J,Aoki A,Kawano K,et al. Journal of the American College of Cardiology . 1997